Condition: Stroke, Acute Ischemic · Sponsor: Zhongming Qiu
The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.
This description comes directly from the study's public registry record.
Zhongfan Ruan · 15616320002 · ruanzhongfan@sina.com
Zhongming Qiu · 13236599269 · qiuzhongmingdoctor@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital, Hengyang Medical School, University of South China | Hengyang, Hunan, China | Recruiting |
| Xiangtan Central Hospital | Xiangtan, Hunan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06388148